FORTE BIOSCIENCES, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- FORTE BIOSCIENCES, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $25.00K.
- FORTE BIOSCIENCES, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $17.00K.
- FORTE BIOSCIENCES, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $1.00K, a 96.30% decline year-over-year.
- FORTE BIOSCIENCES, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $19.00K, a 88.55% decline year-over-year.
- FORTE BIOSCIENCES, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $1.00K, a 98.39% decline from fiscal 2021.
- FORTE BIOSCIENCES, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $62.00K, a 75.88% decline from fiscal 2020.
- FORTE BIOSCIENCES, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $257.00K, a 1.98% increase from fiscal 2019.
- FORTE BIOSCIENCES, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $252.00K, a 276.12% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $25.00K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $17.00K 10-Q · filed 2025-11-14 | |
| 2022-12-31 | $1.00K 10-K · filed 2024-03-18 | |
| 2022-03-31 | $1.00K 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $62.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $19.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $15.00K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $27.00K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $257.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $166.00K 10-Q · filed 2021-11-08 | $258.00K derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $47.00K 10-Q · filed 2021-11-08 | $92.00K derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-03-31 | $45.00K 10-Q · filed 2021-11-08 | $49.00K derived: sum of 4 quarters · filed 2021-11-08 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $252.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $282.00K derived: sum of 4 quarters · filed 2020-04-23 |
| 2019-06-30 | $4.00K 10-Q · filed 2019-08-08 | $285.00K derived: sum of 4 quarters · filed 2020-04-23 |
| 2019-03-31 | $248.00K 10-Q · filed 2020-04-23 | $286.00K derived: sum of 4 quarters · filed 2020-04-23 |
| 2018-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $67.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $3.00K 10-Q · filed 2019-11-12 | $71.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $5.00K 10-Q · filed 2019-08-08 | $68.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $29.00K 10-Q · filed 2019-05-07 | $69.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $81.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | |
| 2017-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | |
| 2017-03-31 | $41.00K 10-Q · filed 2017-05-23 | |
| 2016-12-31 | $10.00K 10-K · filed 2019-02-27 | |
| 2015-12-31 | $157.00K 10-K · filed 2018-03-09 |